-
Real Time Chart
-
Stock Profile
-
Stock Fundamentals
Financials As Reported
-
accession Number
0001370368-22-000010
-
amendment Flag
false
-
assets
131,795,000,000
-
auditor Firm Id
1,358
-
auditor Location
Basel, Switzerland
-
auditor Name
PricewaterhouseCoopers AG
-
cik
1,114,448
-
current Fiscal Year End Date
--12-31
-
date Filed
2022-02-02
-
document Annual Report
true
-
document Fiscal Period Focus
FY
-
document Fiscal Year Focus
2,021
-
document Period End Date
2021-12-31
-
document Transition Report
false
-
document Type
20-F
-
entity Address Address Line 1
Lichtstrasse 35
-
entity Address City Or Town
Basel
-
entity Address Postal Zip Code
4,056
-
entity Central Index Key
1,114,448
-
entity Current Reporting Status
Yes
-
entity Emerging Growth Company
false
-
entity File Number
1-15024
-
entity Filer Category
Large Accelerated Filer
-
entity Incorporation State Country Code
V8
-
entity Interactive Data Current
Yes
-
entity Name
NOVARTIS AG
-
entity Registrant Name
Novartis AG
-
entity Shell Company
false
-
entity Voluntary Filers
No
-
entity Well Known Seasoned Issuer
Yes
-
gross Profit
37,010,000,000
-
icfr Auditor Attestation Flag
true
-
interest Expense
811,000,000
-
irs Number
0
-
liabilities
63,973,000,000
-
noncurrent Assets
86,077,000,000
-
period End
1,640,908,800,000
-
period Start
1,609,459,200,000
-
report Link
https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/nvs-20211231_htm.xml
-
research And Development Expense
9,540,000,000
-
selling General And Administrative Expense
14,886,000,000
-
trading Symbol
NVS
-
update
1970-01-01
-
id
REPORTED_FINANCIALS
-
key
NVS
-
subkey
20-F
-
date
2022-02-02
-
updated
2022-05-14
-
Symbol Info
-
Symbol Over View
-
Technical Analysis
NVS stock fundamentals - financials as reported